Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Changes in causes of death in systemic sclerosis, 1972-2002.

Steen VD, Medsger TA.

Ann Rheum Dis. 2007 Jul;66(7):940-4. Epub 2007 Feb 28.

2.

Severe organ involvement in systemic sclerosis with diffuse scleroderma.

Steen VD, Medsger TA Jr.

Arthritis Rheum. 2000 Nov;43(11):2437-44.

3.

Determinants of morbidity and mortality of systemic sclerosis in Canada.

Al-Dhaher FF, Pope JE, Ouimet JM.

Semin Arthritis Rheum. 2010 Feb;39(4):269-77. doi: 10.1016/j.semarthrit.2008.06.002. Epub 2008 Aug 15.

PMID:
18706680
4.

Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.

Joven BE, Almodovar R, Carmona L, Carreira PE.

Semin Arthritis Rheum. 2010 Feb;39(4):285-93. doi: 10.1016/j.semarthrit.2009.06.002. Epub 2009 Sep 25.

PMID:
19782387
5.

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.

Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Müller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, Miniati I, Ananieva L, Gurman AB, Damjanov N, Mueller A, Valentini G, Riemekasten G, Tikly M, Hummers L, Henriques MJ, Caramaschi P, Scheja A, Rozman B, Ton E, Kumánovics G, Coleiro B, Feierl E, Szucs G, Von Mühlen CA, Riccieri V, Novak S, Chizzolini C, Kotulska A, Denton C, Coelho PC, Kötter I, Simsek I, de la Pena Lefebvre PG, Hachulla E, Seibold JR, Rednic S, Stork J, Morovic-Vergles J, Walker UA.

Ann Rheum Dis. 2010 Oct;69(10):1809-15. doi: 10.1136/ard.2009.114264. Epub 2010 Jun 15.

PMID:
20551155
6.

Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.

Jacobsen S, Ullman S, Shen GQ, Wiik A, Halberg P.

J Rheumatol. 2001 Nov;28(11):2454-9.

PMID:
11708418
7.

Mortality and causes of death in a Swedish series of systemic sclerosis patients.

Hesselstrand R, Scheja A, Akesson A.

Ann Rheum Dis. 1998 Nov;57(11):682-6.

8.

Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.

Nihtyanova SI, Tang EC, Coghlan JG, Wells AU, Black CM, Denton CP.

QJM. 2010 Feb;103(2):109-15. doi: 10.1093/qjmed/hcp174. Epub 2009 Dec 4.

PMID:
19966313
9.

Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension.

Schachna L, Medsger TA Jr, Dauber JH, Wigley FM, Braunstein NA, White B, Steen VD, Conte JV, Yang SC, McCurry KR, Borja MC, Plaskon DE, Orens JB, Gelber AC.

Arthritis Rheum. 2006 Dec;54(12):3954-61.

10.

Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.

Poormoghim H, Lucas M, Fertig N, Medsger TA Jr.

Arthritis Rheum. 2000 Feb;43(2):444-51.

11.

Survival and causes of death in 366 Hungarian patients with systemic sclerosis.

Czirják L, Kumánovics G, Varjú C, Nagy Z, Pákozdi A, Szekanecz Z, Szucs G.

Ann Rheum Dis. 2008 Jan;67(1):59-63. Epub 2007 May 22.

PMID:
17519276
12.

Report on management of renale failure in Europe, XXVI, 1995. Rare diseases in renal replacement therapy in the ERA-EDTA Registry.

Tsakiris D, Simpson HK, Jones EH, Briggs JD, Elinder CG, Mendel S, Piccoli G, dos Santos JP, Tognoni G, Vanrenterghem Y, Valderrabano F.

Nephrol Dial Transplant. 1996;11 Suppl 7:4-20.

PMID:
9067983
13.

Mortality in systemic sclerosis (scleroderma).

Lee P, Langevitz P, Alderdice CA, Aubrey M, Baer PA, Baron M, Buskila D, Dutz JP, Khostanteen I, Piper S, et al.

Q J Med. 1992 Feb;82(298):139-48.

PMID:
1620814
14.

Renal function is mostly preserved in patients with systemic sclerosis.

Scheja A, Bartosik I, Wuttge DM, Hesselstrand R.

Scand J Rheumatol. 2009;38(4):295-8. doi: 10.1080/03009740802629424.

PMID:
19214870
15.

Anti-U3 RNP autoantibodies in systemic sclerosis.

Aggarwal R, Lucas M, Fertig N, Oddis CV, Medsger TA Jr.

Arthritis Rheum. 2009 Apr;60(4):1112-8. doi: 10.1002/art.24409.

16.

Prognostic factors of mortality and 2-year survival analysis of systemic sclerosis with pulmonary arterial hypertension in Thailand.

Foocharoen C, Nanagara R, Kiatchoosakun S, Suwannaroj S, Mahakkanukrauh A.

Int J Rheum Dis. 2011 Aug;14(3):282-9. doi: 10.1111/j.1756-185X.2011.01625.x. Epub 2011 Jun 30.

PMID:
21816025
17.

Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma)

Jacobsen S, Halberg P, Ullman S.

Br J Rheumatol. 1998 Jul;37(7):750-5.

PMID:
9714351
18.

[Progressive systemic scleroderma--prognosis determining involvement of internal organ systems].

Mittag M, Haustein UF.

Hautarzt. 1998 Jul;49(7):545-51. Review. German.

PMID:
9715381
19.

Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors.

Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr.

Ann Intern Med. 1990 Sep 1;113(5):352-7.

PMID:
2382917
20.

Causes of death and poor survival prognostic factors in thai patients with systemic sclerosis.

Ruangjutipopan S, Kasitanon N, Louthrenoo W, Sukitawut W, Wichainun R.

J Med Assoc Thai. 2002 Nov;85(11):1204-9.

PMID:
12546318

Supplemental Content

Support Center